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Endometrial cancer belongs to the most frequently diag-
nosed malignant neoplasms of female genital organs,
and its incidence is steadily growing. For the timebeing,
no chromosomal aberrations have been determined
unequivocally, which would be specific for the particular
stages of endometrial hyperplasia and neoplastic trans-
formation development.
The goal of the undertaken studies was an identifica-
tion of the earliest and specific genetic changes, which
could be attributed to an increased risk of neoplastic
transformation in a group of patients with endometrial
hyperplasia plus the characteristics of genetic changes
associated with the mature form of neoplasm.
The study involved forty-four (44) patients, including
five (5) histopathologically unconfirmed hyperplasia,
twenty-six (26) with histopathologically confirmed endo-
metrial hyperplasia and thirteen (13) with diagnosed
endometrial cancer.
The applied aCGH (array Comparative Genomic
Hybridisation) method enabled selection of a few chro-
mosomal regions which indicated a higher incidence of
chromosomal rearrangements than in the control group.
The study included also an evaluation of the frequency of
mutations of the genes specific for neoplastic transforma-
tion development, the genes at chromosomal loci, which
most frequently presented with genomic imbalance.
In cases without hyperplasia, changes were diagnosed,
described as CNVs (Copy Number Variations), which
occurred with varying prevalence in the genome of the
population of healthy subjects. Significant genomic
imbalance was identified in 26 (100%) patients with
diagnosed hyperplasia and in 11 (84.6%) of the patients
with diagnosed endometrial cancer. Also other, till now
unreported changes were found, localised at characteris-
tic regions of the genome.
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